Device for vaso-occlusion and interventional therapy

• US 20030093111A1
• Filed: 10/25/2002
• Published: 05/15/2003
• Est. Priority Date: 10/26/2001
• Status: Abandoned Application

• Current Assignee: Stryker Corporation
• Original Assignee: Concentric Medical, Inc. (Stryker Corporation)
• Inventors: Ken, Christopher G.M., Patel, Tina J.
• Application Number:
  US10/280,125
• Publication Number:
  US 20030093111A1
• Time in Patent Office: Days
• US Class Current: 606/200
• CPC Class Codes: A61B 17/12022 Occluding by internal devices, e.g. balloons or releasable wires plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20
• CPC Class Codes: A61B 17/12145 having a pre-set deployed three-dimensional shape methods of manufacturing A61B2017/00526
• CPC Class Codes: A61B 17/1215 comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable or resorptive
• CPC Class Codes: A61B 2017/00867 shape memory effect
• CPC Class Codes: A61B 2018/00416 Treatment of aneurisms

Abstract

The invention provides a vaso-occlusive device having a braid comprising a bioabsorbable or bioactive material placed over and retaining a helical metallic coil. The braid or the coil may have one or more fibrous elements attached. A helical metallic coil comprising one or more attached fibrous elements is also claimed and described. Corresponding methods of making these devices and of treating patients having abnormal blood flow by implanting such devices at a site of abnormal blood flow are also claimed and described.

Claims

1. A vaso-occlusive device comprising:

a helical coil wound from a filament of metallic wire;

a flexible braid comprising a bioabsorbable or bioactive material, the braid having a lumen for containing the helical coil, wherein the braid is positioned over the helical coil like a sleeve, and at least a first end of the braid is closed to form a closure to retain the helical coil inside the lumen of the braid.

2. A vaso-occlusive device as in claim 1, wherein the helical coil is heat treated to form a secondary shape.

3. A vaso-occlusive device as in claim 1, wherein a second end of the braid is held in a delivery device to form a temporary closure to retain the helical coil inside the lumen of the braid prior to delivery of the device.

4. A vaso-occlusive device as in claim 1, further comprising that a second end of the braid is closed to form a closure to retain the helical coil inside the lumen of the braid.

5. A vaso-occlusive device as in claim 1, wherein the coil is in contact with the braid by friction.

6. A vaso-occlusive device as in claim 3, wherein the coil is in contact with the braid by friction.

7. A vaso-occlusive device as in claim 1, wherein the closure is provided by a synched portion at an end of the braid.

8. A vaso-occlusive device as in claim 7, wherein the closure is provided by a synched portion at each end of the braid.

9. A vaso-occlusive device as in claim 7, wherein the synched portion is heated to seal the synched portion.

10. A vaso-occlusive device as in claim 8, wherein the synched portions are heated to seal the synched portions.

11. A vaso-occlusive device as in claim 7, wherein the synched portion is mechanically fixed with a tie or other mechanical fixation at the synched end.

12. A vaso-occlusive device as in claim 8, wherein the synched portions are mechanically fixed with a tie or other mechanical fixation at the synched ends.

13. A vaso-occlusive device as in claim 1, wherein at least one end of the braid is attached to a plug comprising a bioabsorbable or bioactive monofilament, wherein the attachment provides closure for an end of the braid.

14. A vaso-occlusive device as in claim 13, wherein an end of the braid is attached to the plug by heat.

15. A vaso-occlusive device as in claim 13, wherein an end of the braid is adhered to the plug to provide closure for the end of the braid.

16. A vaso-occlusive device as in claim 13, wherein an end of the braid is mechanically fixed to the plug to provide closure for the end of the braid.

17. A vaso-occlusive device as in claim 1, wherein the ends of the braid are synched to hold the coil in place and the coil contacts the braid by friction.

18. A vaso-occlusive device as in claim 13, wherein a plug at an end of the braid rests inside the lumen of the braid and a lumen of the coil and is affixed to an end of the braid by either heat, adhesive or mechanical means.

19. A vaso-occlusive device as in claim 1, wherein the helical coil comprises a multifilament metallic strand.

20. A vaso-occlusive device as in claim 1, wherein the metallic wire comprises a metal selected from the group consisting of platinum, stainless steel, nickel-titanium alloy, tungsten, gold, rhenium, palladium, rhodium, ruthenium, titanium, nickel, and alloys thereof.

21. A vaso-occlusive device as in claim 1, wherein the helical coil comprises a multifilament metallic strand.

22. A vaso-occlusive device as in claim 1, wherein the bioabsorbable material comprises a bioabsorbable polymer.

23. A vaso-occlusive device as in claim 1, wherein the bioactive material comprises a polymer that bioabsorbs and generates a bioactive response at a site of implantation in the process.

24. A vaso-occlusive device as in claim 1, wherein the bioactive material comprises a polymer comprising a bioactive agent that generates scar tissue in the healing process.

25. A vaso-occlusive device as in claim 1, wherein the bioabsorbable or bioactive material comprises one or more agents that bioabsorbs or is otherwise bioactive at the site.

26. A vaso-occlusive device as in claim 1, further comprising one or more fibrous elements attached to or extending from the braid.

27. A vaso-occlusive device as in claim 1, further comprising one or more fibrous elements attached to or extending from the helical coil.

28. A vaso-occlusive device comprising:

a helical coil wound from a filament of metallic wire; and

one or more fibrous elements comprising a bioabsorbable or bioactive material, attached to or extending from the coil.

29. A vaso-occlusive device of claim 28, wherein the metal comprises a metal selected from the group consisting of platinum, stainless steel, nickel-titanium alloy, tungsten, gold, rhenium, palladium, rhodium, ruthenium, titanium, nickel, and alloys thereof.

30. A vaso-occlusive device as in claim 28, wherein the helical coil comprises a multifilament metallic strand.

31. A vaso-occlusive device as in claim 28, wherein the bioabsorbable material comprises a bioabsorbable polymer.

32. A vaso-occlusive device as in claim 28, wherein the bioactive material comprises a polymer comprising a bioactive agent that generates scar tissue in the healing process.

33. A vaso-occlusive device as in claim 28, wherein the bioactive material comprises a polymer that bioabsorbs and generates a bioactive response at a site of implantation in the process.

34. A method of making a vaso-occlusive device comprising:

providing a helical coil wound from a filament of metallic wire,

sliding a tubular braid comprising a bioabsorbable or bioactive material over the helical coil, and

closing at least a first end of the braid to form a closure to retain the helical coil inside the lumen of the braid.

35. A method as in claim 34, wherein the filament of metallic wire comprise a metal selected from the group consisting of platinum, stainless steel, nickel-titanium alloy, tungsten, gold, rhenium, palladium, rhodium, ruthenium, titanium, nickel, and alloys thereof.

36. A method as in claim 34, wherein the bioabsorbable material comprises a bioabsorbable polymer.

37. A method as in claim 34, wherein the bioactive material comprises a polymer comprising a bioactive agent that generates scar tissue in the healing process.

38. A method as in claim 34, wherein the bioactive material comprises a polymer that bioabsorbs and generates a bioactive response at a site of implantation in the process.

39. A method as in claim 34, further comprising heat treating the helical coil to form a secondary shape.

40. A method as in claim 39, wherein the secondary shape formed by heat treating is assumable after sliding the braid over the coil, and after delivery of the device to the patient.

41. A method as in claim 34, wherein closing comprises a procedure selected from the group consisting of synching at least one end of the braid to form a closure of the braid, providing a monofilament plug comprising a bioabsorbable or bioactive material affixed to at least one end of the braid to form a closure of the braid, and placing a plug comprising a bioabsorbable or bioactive material into a lumen of the tubular braid and a lumen of the helical coil wherein the plug is affixed to an end of the braid by heat, adherence, or mechanical fixation.

42. A method as in claim 34, wherein providing a helical coil comprises winding a primary coil made from a multifilament strand.

43. A method as in claim 34, further comprising attaching one or more fibrous elements comprising a bioabsorbable or bioactive material to the braid.

44. A method as in claim 34, further comprising attaching one or more fibrous elements comprising a bioabsorbable or bioactive material to the coil.

45. A method of making a vaso-occlusive device comprising:

providing a helical coil wound from a filament of metallic wire, and

attaching one or more fibrous elements to the coil, wherein the fibrous element comprises a bioabsorbable or bioactive material.

46. A method of claim 45, wherein the metal is selected from the group consisting of platinum, stainless steel, nickel-titanium alloy, tungsten, gold, rhenium, palladium, rhodium, ruthenium, titanium, nickel, and alloys thereof.

47. A method as in claim 45, wherein the coil comprises a multifilament metal strand.

48. A method of treating a patient having abnormal blood flow at a site comprising:

providing a helical coil wound from a filament of metallic wire and a flexible braid comprising a bioabsorbable or bioactive material, the braid having a lumen for containing the helical coil, wherein the braid is positioned over the helical coil like a sleeve, and at least a first end of the braid is closed to form a closure to retain the helical coil inside the lumen of the braid; and

implanting said coil at the site of abnormal blood flow in the patient.

49. A method as in claim 48, wherein the site of abnormal blood flow comprises a condition selected from the group consisting of ruptured blood vessels, aneurysms, arterio venus malformations (AVMs), fistulas, benign tumors, and malignant tumors.

50. A method of treating a patient having abnormal blood flow at a site comprising:

providing a helical coil wound from a filament of metallic wire and a flexible braid comprising a bioabsorbable or bioactive material, the braid having a lumen for containing the helical coil, wherein the braid is positioned over the helical coil like a sleeve, at least a first end of the braid is closed to form a closure to retain the helical coil inside the lumen of the braid, and attached to the braid or the coil is one or more fibrous elements comprising a bioabsorbable or bioactive material; and

implanting said coil at the site of abnormal blood flow in the patient.

52. A method as in claim 50, wherein the site of abnormal blood flow comprises a condition selected from the group consisting of ruptured blood vessels, aneurysms, arterio venus malformations (AVMs), fistulas, benign tumors, and malignant tumors.

51. A method of treating a patient having abnormal blood flow at a site comprising:

providing a helical coil wound from a filament of metallic wire comprising one or more fibrous elements comprising a bioabsorbable or bioactive material attached to the coil; and

implanting said coil at the site of abnormal blood flow in the patient.

53. A method as in claim 51, wherein the site of abnormal blood flow comprises a condition selected from the group consisting of ruptured blood vessels, aneurysms, arterio venus malformations (AVMs), fistulas, benign tumors, and malignant tumors.